Join the seminar via digital streaming to learn about the challenges in precision medicine from the perspective of health economics, discuss the landscape of precision medicine and how current guidelines and regulations needs to be updated and adjusted. Keep tabs on this page for more information!
Stakeholders include health economists, researchers, clinicians, industry and public organizations
Background. Reimbursement of pharmaceuticals is based on cost-effectiveness analysis. These analyses synthesize information from multiple sources, where the efficacy typically is based on information from randomized controlled trials.
The introduction of precision medicine implies several challenges for the recommended framework:
There will be opportunities for Q&As throughout the seminar!
Registration. Register for a digital attendance via the page for Events! Questions about registration? Contact Mari Eide Frey, Project Coordinator, BigMed.
Please, reach out to the contacts listed below if you have any further questions.
University of Oslo